Follow-up for delayed side effects after gene-cell therapy
Part of Blood & lymphatic, Cancer clinical trials.
This study checks people for delayed side effects after receiving gene-based cell therapy from the NIH. It helps doctors learn what problems may happen later and how to monitor them safely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You took part in a pediatric oncology gene-cell therapy study run by the Pediatric Oncology Branch (POB) or are currently eligible to join one
- You received, or are scheduled to receive, genetically engineered (gene-modified) cell therapy
- Your follow-up tests must be about the gene-cell therapy you received at the National Institutes of Health (NIH)
- If you received similar gene-cell therapy at another hospital, this study will not monitor those cells
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is a follow-up study for people age 18 or older who previously took part in a CAR T-cell gene therapy trial. It helps researchers check your health over time after that treatment and supports long-term safety and outcomes tracking.
This study monitors participants who received a certain type of CAR T-cell therapy for cancer. It helps researchers understand long-term effects and safety.
This study checks how people do long-term after stem cell transplant, cellular therapy, or gene therapy. It may help doctors track longer-term health effects and recovery and improve future care.
This study is a follow-up check for people who were previously enrolled in certain NCI gene therapy treatment studies. It helps the research team monitor long-term effects and outcomes after treatment.
This study follows people who have already received a CRISPR CAR T cell therapy to monitor their long-term health and any side effects. It helps doctors understand how these treatments work over time.
This study follows children and young adults who received CAR T cell therapy to understand any long-term side effects that may appear months to years later. By joining, you help researchers learn how to better care for patients after this treatment.
Hear when a new Pediatric Cancers trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.